MR and CT Imaging for the Evaluation of Pulmonary Hypertension

JACC: Cardiovascular Imaging

Volumn 9, Issue 6, 2016, Pages 715-732

  Freed, Benjamin H ^a   Collins, Jeremy D ^a   François, Christopher J ^b   Barker, Alex J ^a   Cuttica, Michael J ^b   Chesler, Naomi C ^a   Markl, Michael ^a   Shah, Sanjiv J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

anatomy; computed tomography; magnetic resonance imaging; physiology; pulmonary hypertension; pulmonary vasculature; right ventricle

Indexed keywords

BOSENTAN; PROSTACYCLIN; SILDENAFIL; SIMVASTATIN;

CARDIOPULMONARY HEMODYNAMICS; CARDIOVASCULAR MAGNETIC RESONANCE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY BLOOD FLOW; DOPPLER ECHOCARDIOGRAPHY; HEART CATHETERIZATION; HEART FUNCTION; HEART MUSCLE PERFUSION; HEART OUTPUT; HEART RIGHT VENTRICLE FUNCTION; HUMAN; INTERVENTRICULAR SEPTUM; LUNG BLOOD VESSEL; LUNG CIRCULATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; REVIEW; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; YOUNG MODULUS; ARTERIAL PRESSURE; DIAGNOSTIC IMAGING; HEART LEFT VENTRICLE FUNCTION; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS; SCINTIGRAPHY;

ARTERIAL PRESSURE; COMPUTED TOMOGRAPHY ANGIOGRAPHY; HUMANS; HYPERTENSION, PULMONARY; MAGNETIC RESONANCE IMAGING; PERFUSION IMAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PULMONARY ARTERY; PULMONARY CIRCULATION; VENTRICULAR FUNCTION, LEFT; VENTRICULAR FUNCTION, RIGHT;

EID: 84978196575     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2015.12.015     Document Type: Review

References (78)

1. 1 McLaughlin, V.V., Shah, S.J., Souza, R., Humbert, M., Management of pulmonary arterial hypertension. J Am Coll Cardiol 65 (2015), 1976–1997.
2. 2 Shah, S.J., Pulmonary hypertension. JAMA 308 (2012), 1366–1374.
3. 3 Peacock, A.J., Crawley, S., McLure, L., et al. Changes in right ventricular function measured by cardiac magnetic resonance imaging in patients receiving pulmonary arterial hypertension-targeted therapy: the EURO-MR study. Circ Cardiovasc Imaging 7 (2014), 107–114.
4. 4 Grothues, F., Moon, J.C., Bellenger, N.G., Smith, G.S., Klein, H.U., Pennell, D.J., Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance. Am Heart J 147 (2004), 218–223.
5. 5 Grothues, F., Smith, G.C., Moon, J.C., et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 90 (2002), 29–34.
6. 6 Jauhiainen, T., Jarvinen, V.M., Hekali, P.E., Evaluation of methods for MR imaging of human right ventricular heart volumes and mass. Acta Radiol 43 (2002), 587–592.
7. 7 Hori, Y., Yamada, N., Higashi, M., Hirai, N., Nakatani, S., Rapid evaluation of right and left ventricular function and mass using real-time true-FISP cine MR imaging without breath-hold: comparison with segmented true-FISP cine MR imaging with breath-hold. J Cardiovasc Magn Reson 5 (2003), 439–450.
8. 8 Peacock, A.J., Vonk Noordegraaf, A., Cardiac magnetic resonance imaging in pulmonary arterial hypertension. Eur Respir Rev 22 (2013), 526–534.
9. 9 van Wolferen, S.A., van de Veerdonk, M.C., Mauritz, G.J., et al. Clinically significant change in stroke volume in pulmonary hypertension. Chest 139 (2011), 1003–1009.
10. 10 Buckberg, G.D., RESTORE Group. The ventricular septum: the lion of right ventricular function, and its impact on right ventricular restoration. Eur J Cardiothorac Surg 29:Suppl 1 (2006), S272–S278.
11. 11 Gan, C., Lankhaar, J.W., Marcus, J.T., et al. Impaired left ventricular filling due to right-to-left ventricular interaction in patients with pulmonary arterial hypertension. Am J Physiol Heart Circ Physiol 290 (2006), H1528–H1533.
12. 12 Marcus, J.T., Gan, C.T., Zwanenburg, J.J., et al. Interventricular mechanical asynchrony in pulmonary arterial hypertension: left-to-right delay in peak shortening is related to right ventricular overload and left ventricular underfilling. J Am Coll Cardiol 51 (2008), 750–757.
13. 13 Haddad, F., Guihaire, J., Skhiri, M., et al. Septal curvature is marker of hemodynamic, anatomical, and electromechanical ventricular interdependence in patients with pulmonary arterial hypertension. Echocardiography 31 (2014), 699–707.
14. 14 Roeleveld, R.J., Marcus, J.T., Faes, T.J., et al. Interventricular septal configuration at MR imaging and pulmonary arterial pressure in pulmonary hypertension. Radiology 234 (2005), 710–717.
15. 15 Alunni, J.P., Degano, B., Arnaud, C., et al. Cardiac MRI in pulmonary artery hypertension: correlations between morphological and functional parameters and invasive measurements. Eur Radiol 20 (2010), 1149–1159.
16. 16 Sciancalepore, M.A., Maffessanti, F., Patel, A.R., et al. Three-dimensional analysis of interventricular septal curvature from cardiac magnetic resonance images for the evaluation of patients with pulmonary hypertension. Int J Cardiovasc Imaging 28 (2012), 1073–1085.
17. 17 Sato, T., Tsujino, I., Ohira, H., et al. Paradoxical interventricular septal motion as a major determinant of late gadolinium enhancement in ventricular insertion points in pulmonary hypertension. PLoS One, 8, 2013, e66724.
18. 18 Pelc, N.J., Sommer, F.G., Li, K.C.P., Brosnan, T.J., Herfkens, R.J., Enzmann, D.R., Quantitative magnetic resonance flow imaging. Magn Reson Q 10 (1994), 125–147.
19. 19 Ley, S., Mereles, D., Puderbach, M., et al. Value of MR phase-contrast flow measurements for functional assessment of pulmonary arterial hypertension. Eur Radiol 17 (2007), 1892–1897.
20. 20 Kondo, C., Caputo, G.R., Masui, T., et al. Pulmonary hypertension: pulmonary flow quantification and flow profile analysis with velocity-encoded cine MR imaging. Radiology 183 (1992), 751–758.
21. 21 Mousseaux, E., Tasu, J.P., Jolivet, O., Simonneau, G., Bittoun, J., Gaux, J.C., Pulmonary arterial resistance: noninvasive measurement with indexes of pulmonary flow estimated at velocity-encoded MR imaging—preliminary experience. Radiology 212 (1999), 896–902.
22. 22 Bogren, H.G., Klipstein, R.H., Mohiaddin, R.H., et al. Pulmonary artery distensibility and blood flow patterns: a magnetic-resonance study of normal subjects and of patients with pulmonary arterial-hypertension. Am Heart J 118 (1989), 990–999.
23. 23 Sanz, J., Kariisa, M., Dellegrottaglie, S., et al. Evaluation of pulmonary artery stiffness in pulmonary hypertension with cardiac magnetic resonance. J Am Coll Cardiol Img 2 (2009), 286–295.
24. 24 Bellofiore, A., Chesler, N.C., Methods for measuring right ventricular function and hemodynamic coupling with the pulmonary vasculature. Ann Biomed Eng 41 (2013), 1384–1398.
25. 25 Gan, C.T., Lankhaar, J.W., Westerhof, N., et al. Noninvasively assessed pulmonary artery stiffness predicts mortality in pulmonary arterial hypertension. Chest 132 (2007), 1906–1912.
26. 26 Ohno, Y., Hatabu, H., Murase, K., et al. Primary pulmonary hypertension: 3D dynamic perfusion MRI for quantitative analysis of regional pulmonary perfusion. AJR Am J Roentgenol 188 (2007), 48–56.
27. 27 Ohno, Y., Murase, K., Higashino, T., et al. Assessment of bolus injection protocol with appropriate concentration for quantitative assessment of pulmonary perfusion by dynamic contrast-enhanced MR imaging. J Magn Reson Imaging 25 (2007), 55–65.
28. 28 Swift, A.J., Wild, J.M., Nagle, S.K., et al. Quantitative magnetic resonance imaging of pulmonary hypertension: a practical approach to the current state of the art. J Thorac Imaging 29 (2014), 68–79.
29. 29 Sanz, J., Garcia-Alvarez, A., Fernandez-Friera, L., et al. Right ventriculo-arterial coupling in pulmonary hypertension: a magnetic resonance study. Heart 98 (2012), 238–243.
30. 30 Freed, B.H., Gomberg-Maitland, M., Chandra, S., et al. Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension. J Cardiovasc Magn Reson, 14, 2012, 11.
31. 31 Shehata, M.L., Lossnitzer, D., Skrok, J., et al. Myocardial delayed enhancement in pulmonary hypertension: pulmonary hemodynamics, right ventricular function, and remodeling. AJR Am J Roentgenol 196 (2011), 87–94.
32. 32 Vogel-Claussen, J., Shehata, M.L., Lossnitzer, D., et al. Increased right ventricular septomarginal trabeculation mass is a novel marker for pulmonary hypertension: comparison with ventricular mass index and right ventricular mass. Invest Radiol 46 (2011), 567–575.
33. 33 Mewton, N., Liu, C.Y., Croisille, P., Bluemke, D., Lima, J.A., Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol 57 (2011), 891–903.
34. 1 mapping. J Am Coll Cardiol 52 (2008), 1574–1580.
35. 35 Won, S., Davies-Venn, C., Liu, S., Bluemke, D.A., Noninvasive imaging of myocardial extracellular matrix for assessment of fibrosis. Curr Opin Cardiol 28 (2013), 282–289.
36. 1-mapping CMR with hemodynamics and RV performance in pulmonary hypertension. J Am Coll Cardiol Img 8 (2015), 76–82.
37. 1 mapping of the right ventricle. Magn Reson Med 73 (2015), 150–160.
38. 1 values of the right-ventricular myocardium by cardiac MRI. Int J Cardiovasc Imaging 30 (2014), 323–328.
39. 39 Tee, M., Noble, J.A., Bluemke, D.A., Imaging techniques for cardiac strain and deformation: comparison of echocardiography, cardiac magnetic resonance and cardiac computed tomography. Expert Rev Cardiovasc Ther 11 (2013), 221–231.
40. 40 Osman, N.F., Kerwin, W.S., McVeigh, E.R., Prince, J.L., Cardiac motion tracking using CINE harmonic phase (HARP) magnetic resonance imaging. Magn Reson Med 42 (1999), 1048–1060.
41. 41 Aletras, A.H., Ingkanisorn, W.P., Mancini, C., Arai, A.E., DENSE with SENSE. J Magn Reson 176 (2005), 99–106.
42. 42 Freed, B.H., Tsang, W., Bhave, N.M., et al. Right ventricular strain in pulmonary arterial hypertension: a 2D echocardiography and cardiac magnetic resonance study. Echocardiography 32 (2015), 257–263.
43. 43 Schuster, A., Morton, G., Hussain, S.T., et al. The intra-observer reproducibility of cardiovascular magnetic resonance myocardial feature tracking strain assessment is independent of field strength. Eur J Radiol 82 (2013), 296–301.
44. 44 Meris, A., Faletra, F., Conca, C., et al. Timing and magnitude of regional right ventricular function: a speckle tracking-derived strain study of normal subjects and patients with right ventricular dysfunction. J Am Soc Echocardiogr 23 (2010), 823–831.
45. 45 Shehata, M.L., Harouni, A.A., Skrok, J., et al. Regional and global biventricular function in pulmonary arterial hypertension: a cardiac MR imaging study. Radiology 266 (2013), 114–122.
46. 46 Mauritz, G.J., Vonk-Noordegraaf, A., Kind, T., et al. Pulmonary endarterectomy normalizes interventricular dyssynchrony and right ventricular systolic wall stress. J Cardiovasc Magn Reson, 14, 2012, 5.
47. 47 van Wolferen, S.A., Marcus, J.T., Westerhof, N., et al. Right coronary artery flow impairment in patients with pulmonary hypertension. Eur Heart J 29 (2008), 120–127.
48. 48 Vogel-Claussen, J., Skrok, J., Shehata, M.L., et al. Right and left ventricular myocardial perfusion reserves correlate with right ventricular function and pulmonary hemodynamics in patients with pulmonary arterial hypertension. Radiology 258 (2011), 119–127.
49. 49 Reiter, G., Reiter, U., Kovacs, G., et al. Magnetic resonance-derived 3-dimensional blood flow patterns in the main pulmonary artery as a marker of pulmonary hypertension and a measure of elevated mean pulmonary arterial pressure. Circ Cardiovasc Imaging 1 (2008), 23–30.
50. 50 Reiter, U., Reiter, G., Kovacs, G., et al. Evaluation of elevated mean pulmonary arterial pressure based on magnetic resonance 4D velocity mapping: comparison of visualization techniques. PLoS One, 8, 2013, e82212.
51. 51 Truong, U., Fonseca, B., Dunning, J., et al. Wall shear stress measured by phase contrast cardiovascular magnetic resonance in children and adolescents with pulmonary arterial hypertension. J Cardiovasc Magn Reson, 15, 2013, 81.
52. 52 Chien, S., Li, S., Shyy, Y.J., Effects of mechanical forces on signal transduction and gene expression in endothelial cells. Hypertension 31 (1998), 162–169.
53. 53 Fenster, B.E., Browning, J., Schroeder, J.D., et al. Vorticity is a Marker of Right Ventricular Diastolic Dysfunction. Am J Physiol Heart Circ Physiol 309 (2015), H1087–H1093.
54. 54 Kopec, G., Moertl, D., Jankowski, P., Tyrka, A., Sobien, B., Podolec, P., Pulmonary artery pulse wave velocity in idiopathic pulmonary arterial hypertension. Can J Cardiol 29 (2013), 683–690.
55. 55 François, C.J., Srinivasan, S., Schiebler, M.L., et al. 4D cardiovascular magnetic resonance velocity mapping of alterations of right heart flow patterns and main pulmonary artery hemodynamics in tetralogy of Fallot. J Cardiovasc Magn Reson, 14, 2012, 16.
56. 56 Fredriksson, A.G., Zajac, J., Eriksson, J., et al. 4-D blood flow in the human right ventricle. Am J Physiol Heart Circ Physiol 301 (2011), H2344–H2350.
57. 57 Nordmeyer, S., Riesenkampff, E., Messroghli, D., et al. Four-dimensional velocity-encoded magnetic resonance imaging improves blood flow quantification in patients with complex accelerated flow. J Magn Reson Imaging 37 (2013), 208–216.
58. 58 Nordmeyer, S., Riesenkampff, E., Crelier, G., et al. Flow-sensitive four-dimensional cine magnetic resonance imaging for offline blood flow quantification in multiple vessels: a validation study. J Magn Reson Imaging 32 (2010), 677–683.
59. 59 Markl, M., Wallis, W., Harloff, A., Reproducibility of flow and wall shear stress analysis using flow-sensitive four-dimensional MRI. J Magn Reson Imaging 33 (2011), 988–994.
60. 60 Frydrychowicz, A., Wieben, O., Niespodzany, E., Reeder, S.B., Johnson, K.M., François, C.J., Quantification of thoracic blood flow using volumetric magnetic resonance imaging with radial velocity encoding: in vivo validation. Invest Radiol 48 (2013), 819–825.
61. 61 Geiger, J., Markl, M., Jung, B., et al. 4D-MR flow analysis in patients after repair for tetralogy of Fallot. Eur Radiol 21 (2011), 1651–1657.
62. 62 Roldan-Alzate, A., Frydrychowicz, A., Johnson, K.M., et al. Non-invasive assessment of cardiac function and pulmonary vascular resistance in an canine model of acute thromboembolic pulmonary hypertension using 4D flow cardiovascular magnetic resonance. J Cardiovasc Magn Reson, 16, 2014, 23.
63. 63 Tang, B.T., Pickard, S.S., Chan, F.P., Tsao, P.S., Taylor, C.A., Feinstein, J.A., Wall shear stress is decreased in the pulmonary arteries of patients with pulmonary arterial hypertension: an image-based, computational fluid dynamics study. Pulm Circ 2 (2012), 470–476.
64. 64 Wang, Z., Lakes, R.S., Golob, M., Eickhoff, J.C., Chesler, N.C., Changes in large pulmonary arterial viscoelasticity in chronic pulmonary hypertension. PLoS One, 8, 2013, e78569.
65. 65 Lammers, S.R., Kao, P.H., Qi, H.J., et al. Changes in the structure-function relationship of elastin and its impact on the proximal pulmonary arterial mechanics of hypertensive calves. Am J Physiol Heart Circ Physiol 295 (2008), H1451–H1459.
66. 66 Kobs, R.W., Muvarak, N.E., Eickhoff, J.C., Chesler, N.C., Linked mechanical and biological aspects of remodeling in mouse pulmonary arteries with hypoxia-induced hypertension. Am J Physiol Heart Circ Physiol 288 (2005), H1209–H1217.
67. 67 Barker, A.J., Roldan-Alzate, A., Entezari, P., et al. Four-dimensional flow assessment of pulmonary artery flow and wall shear stress in adult pulmonary arterial hypertension: results from two institutions. Magn Reson Med 73 (2015), 1904–1913.
68. 68 Chan, A.L., Juarez, M.M., Shelton, D.K., et al. Novel computed tomographic chest metrics to detect pulmonary hypertension. BMC Med Imaging, 11, 2011, 7.
69. 69 Dournes, G., Verdier, D., Montaudon, M., et al. Dual-energy CT perfusion and angiography in chronic thromboembolic pulmonary hypertension: diagnostic accuracy and concordance with radionuclide scintigraphy. Eur Radiol 24 (2014), 42–51.
70. 70 Gomberg-Maitland, M., Bull, T.M., Saggar, R., et al. New trial designs and potential therapies for pulmonary artery hypertension. J Am Coll Cardiol 62:Suppl 25 (2013), D82–D91.
71. 71 Addetia, K., Bhave, N.M., Tabit, C.E., et al. Sample size and cost analysis for pulmonary arterial hypertension drug trials using various imaging modalities to assess right ventricular size and function end points. Circ Cardiovasc Imaging 7 (2014), 115–124.
72. 72 Centers for Medicare and Medicaid Services. Physician Fee Schedule. Available at: https://www.cms.gov/apps/physician-fee-schedule/overview.aspx. Accessed October 26, 2015.
73. 73 Wilkins, M.R., Paul, G.A., Strange, J.W., et al. Sildenafil versus endothelin receptor antagonist for pulmonary hypertension (SERAPH) study. Am J Respir Crit Care Med 171 (2005), 1292–1297.
74. 74 Wilkins, M.R., Ali, O., Bradlow, W., et al. Simvastatin as a treatment for pulmonary hypertension trial. Am J Respir Crit Care Med 181 (2010), 1106–1113.
75. 75 Roeleveld, R.J., Vonk-Noordegraaf, A., Marcus, J.T., et al. Effects of epoprostenol on right ventricular hypertrophy and dilatation in pulmonary hypertension. Chest 125 (2004), 572–579.
76. 76 van Wolferen, S.A., Boonstra, A., Marcus, J.T., et al. Right ventricular remodelling after sildenafil in pulmonary arterial hypertension. Heart 92 (2006), 1860–1861.
77. 77 Chin, K.M., Kingman, M., de Lemos, J.A., et al. Changes in right ventricular structure and function assessed using cardiac magnetic resonance imaging in bosentan-treated patients with pulmonary arterial hypertension. Am J Cardiol 101 (2008), 1669–1672.
78. 78 Peacock, A.J., Crawley, S., McLure, L., et al. Changes in right ventricular function measured by cardiac magnetic resonance imaging in patients receiving pulmonary arterial hypertension-targeted therapy: the EURO-MR study. Circ Cardiovasc Imaging 7 (2014), 107–114.